Yu‐Pei Chen

11.4k total citations · 2 hit papers
135 papers, 5.5k citations indexed

About

Yu‐Pei Chen is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Yu‐Pei Chen has authored 135 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Otorhinolaryngology, 44 papers in Oncology and 33 papers in Surgery. Recurrent topics in Yu‐Pei Chen's work include Head and Neck Cancer Studies (50 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Lung Cancer Treatments and Mutations (14 papers). Yu‐Pei Chen is often cited by papers focused on Head and Neck Cancer Studies (50 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Lung Cancer Treatments and Mutations (14 papers). Yu‐Pei Chen collaborates with scholars based in China, Taiwan and United States. Yu‐Pei Chen's co-authors include Jun Ma, Ying Sun, Quynh‐Thu Le, Anthony T.�C. Chan, Pierre Blanchard, Ling‐Long Tang, Yan‐Ping Mao, Guan‐Qun Zhou, Lei Chen and Ai-Hua Lin and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Yu‐Pei Chen

127 papers receiving 5.5k citations

Hit Papers

Nasopharyngeal carcinoma 2018 2026 2020 2023 2019 2018 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nasopharyngeal carcinoma
    2019 2.0k citations Yu‐Pei Chen, Anthony T.�C. Chan et al. The Lancet profile →
  2. Comparative safety of immune checkpoint inhibitors in cancer: systematic review and network meta-analysis
    2018 416 citations Cheng Xu, Yu‐Pei Chen et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yu‐Pei Chen 2.1k 1.9k 1.3k 1.2k 1.1k 135 5.5k
Guojun Li 1.6k 0.7× 1.2k 0.6× 2.5k 1.9× 581 0.5× 957 0.9× 279 5.7k
Yunpeng Yang 2.4k 1.1× 323 0.2× 951 0.7× 1.5k 1.3× 513 0.5× 220 4.1k
Veli‐Matti Kosma 2.5k 1.2× 444 0.2× 4.1k 3.0× 842 0.7× 935 0.9× 200 9.0k
Michael Hauptmann 2.7k 1.3× 440 0.2× 2.0k 1.5× 1.9k 1.6× 1.0k 0.9× 191 9.1k
Gang Wu 813 0.4× 454 0.2× 624 0.5× 982 0.8× 514 0.5× 170 3.1k
Chen Hu 1.8k 0.9× 214 0.1× 738 0.5× 2.9k 2.4× 612 0.6× 282 6.7k
Isildinha M. Reis 1.5k 0.7× 159 0.1× 713 0.5× 641 0.5× 527 0.5× 180 3.6k
Junjie Wang 1.4k 0.7× 124 0.1× 1.7k 1.3× 1.2k 1.0× 918 0.8× 296 5.3k
Hui Luo 2.7k 1.3× 143 0.1× 2.4k 1.8× 1.3k 1.1× 1.1k 1.0× 291 6.6k
Tse‐Ching Chen 1.3k 0.6× 145 0.1× 1.2k 0.9× 828 0.7× 818 0.8× 192 4.8k

Countries citing papers authored by Yu‐Pei Chen

Since Specialization
Citations

This map shows the geographic impact of Yu‐Pei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Pei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Pei Chen more than expected).

Fields of papers citing papers by Yu‐Pei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Pei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Pei Chen. The network helps show where Yu‐Pei Chen may publish in the future.

Co-authorship network of co-authors of Yu‐Pei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Pei Chen. A scholar is included among the top collaborators of Yu‐Pei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Pei Chen. Yu‐Pei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
You, Shuai, Fang Xu, Siyu Qin, et al.. (2023). Effect of intraoperative noise on postoperative pain in surgery patients under general anesthesia: evidence from a prospective study and mouse model. International Journal of Surgery. 109(12). 3872–3882. 5 indexed citations
2.
3.
4.
Wang, Liwen, Yixuan Wang, Yu‐Pei Chen, et al.. (2022). Iron Activates cGAS-STING Signaling and Promotes Hepatic Inflammation. Journal of Agricultural and Food Chemistry. 70(7). 2211–2220. 36 indexed citations
5.
Mao, Yan‐Ping, Shunxin Wang, William M. Lydiatt, et al.. (2021). Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: Potential improvement for future editions of N category systems. Radiotherapy and Oncology. 157. 114–121. 41 indexed citations
6.
Wang, Yaqin, Lei Chen, Yan‐Ping Mao, et al.. (2020). Prognostic value of immune score in nasopharyngeal carcinoma using digital pathology. Journal for ImmunoTherapy of Cancer. 8(2). e000334–e000334. 32 indexed citations
7.
Zhao, Yin, Kang Li, Ying‐Qin Li, et al.. (2020). ZNF582 hypermethylation promotes metastasis of nasopharyngeal carcinoma by regulating the transcription of adhesion molecules Nectin‐3 and NRXN3. Cancer Communications. 40(12). 721–737. 21 indexed citations
8.
Lv, Jia‐Wei, Yu‐Pei Chen, Guan‐Qun Zhou, et al.. (2019). Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma. Nature Communications. 10(1). 3941–3941. 111 indexed citations
9.
Wang, Yaqin, Jia-Wei Lv, Ling‐Long Tang, et al.. (2019). Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual. Oral Oncology. 90. 23–29. 9 indexed citations
10.
Li, Li, Yuli Shan, Yalin Lei, et al.. (2019). Decoupling of economic growth and emissions in China’s cities: A case study of the Central Plains urban agglomeration. Applied Energy. 244. 36–45. 89 indexed citations
11.
Lv, Jia‐Wei, Junyan Li, Linna Luo, Zixian Wang, & Yu‐Pei Chen. (2019). Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials. Journal for ImmunoTherapy of Cancer. 7(1). 159–159. 55 indexed citations
12.
Peng, Liang, et al.. (2019). The next decade of clinical trials in locoregionally advanced nasopharyngeal carcinoma. British Journal of Radiology. 92(1102). 20181031–20181031. 20 indexed citations
13.
Chen, Yu‐Pei, Anthony T.�C. Chan, Quynh‐Thu Le, et al.. (2019). Nasopharyngeal carcinoma. The Lancet. 394(10192). 64–80. 1996 indexed citations breakdown →
14.
Peng, Liang, Cheng Xu, Yu‐Pei Chen, et al.. (2018). Optimizing the cumulative cisplatin dose during radiotherapy in nasopharyngeal carcinoma: Dose-effect analysis for a large cohort. Oral Oncology. 89. 102–106. 15 indexed citations
15.
Wang, Yaqin, Yu‐Pei Chen, Yu Zhang, et al.. (2018). Prognostic significance of tumor‐infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large‐scale cohort study. International Journal of Cancer. 142(12). 2558–2566. 72 indexed citations
16.
Tang, Ling‐Long, Yu‐Pei Chen, Yan‐Ping Mao, et al.. (2017). Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era. Journal of the National Comprehensive Cancer Network. 15(7). 913–919. 139 indexed citations
17.
Lv, Jia-Wei, Yu‐Pei Chen, Guan‐Qun Zhou, et al.. (2017). Do Published Data in Trials Assessing Cancer Drugs Reflect the Real Picture of Efficacy and Safety?. Journal of the National Comprehensive Cancer Network. 15(11). 1363–1371. 5 indexed citations
18.
Chang, Ching-Tu, Yu‐Pei Chen, Yu‐Pei Chen, et al.. (2012). Effect of noble metal on oxidative steam reforming of methanol over CuO/ZnO/Al2O3 catalysts. International Journal of Hydrogen Energy. 37(15). 11176–11184. 40 indexed citations
19.
Chang, Ching-Tu, et al.. (2008). Characteristics of Au/MgxAlO hydrotalcite catalysts in CO selective oxidation. Journal of Molecular Catalysis A Chemical. 300(1-2). 80–88. 15 indexed citations
20.
Chen, Gan‐Lin, et al.. (2000). The Formulation Design for Pioglitazone Rapid-Release Tablet. Zhōnghuá yàoxué zázhì. 52(5). 295–303. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guojun Li Breakdown of academic impact, for papers by Yunpeng Yang Breakdown of academic impact, for papers by Veli‐Matti Kosma Breakdown of academic impact, for papers by Michael Hauptmann Breakdown of academic impact, for papers by Gang Wu Breakdown of academic impact, for papers by Chen Hu Breakdown of academic impact, for papers by Isildinha M. Reis Breakdown of academic impact, for papers by Junjie Wang Breakdown of academic impact, for papers by Hui Luo Breakdown of academic impact, for papers by Tse‐Ching Chen
Rankless by CCL
2026